このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

MedCap マネジメント

マネジメント基準チェック /34

MedCap'sの CEO はAnders Dahlbergで、 Nov2020年に任命され、の在任期間は 3.58年です。の年間総報酬はSEK 6.57Mで、 45.3%給与と54.7%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.13%を直接所有しており、その価値はSEK 10.41M 。経営陣と取締役会の平均在任期間はそれぞれ3.6年と2.1年です。

主要情報

Anders Dahlberg

最高経営責任者

SEK 6.6m

報酬総額

CEO給与比率	45.3%
CEO在任期間	3.7yrs
CEOの所有権	0.1%
経営陣の平均在職期間	3.7yrs
取締役会の平均在任期間	2.2yrs

経営陣の近況

Recent updates

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

Jun 06

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

May 21

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

May 04

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 15

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

Jan 22

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Jan 07

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

Dec 22

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Dec 08

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Nov 23

CEO報酬分析

MedCap の収益と比較して、Anders Dahlberg の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	SEK 203m
Dec 31 2023	SEK 7m	SEK 3m	SEK 172m
Sep 30 2023	n/a	n/a	SEK 150m
Jun 30 2023	n/a	n/a	SEK 149m
Mar 31 2023	n/a	n/a	SEK 123m
Dec 31 2022	SEK 7m	SEK 3m	SEK 118m
Sep 30 2022	n/a	n/a	SEK 118m
Jun 30 2022	n/a	n/a	SEK 107m
Mar 31 2022	n/a	n/a	SEK 102m
Dec 31 2021	SEK 6m	SEK 3m	SEK 97m

報酬と市場: Andersの総報酬 ($USD 629.31K ) は、 Swedish市場 ($USD 753.79K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Andersの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Anders Dahlberg (48 yo)

3.7yrs

在職期間

SEK 6,567,000

報酬

Mr. Anders Dahlberg serves as the Chief Executive Officer at MedCap AB, since November 1, 2020. Previously he served as Partner of Applied Value AB till August 2017, where he also had been a Chairman. Mr....

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Anders Dahlberg	Chief Executive Officer	3.7yrs	SEK 6.57m	0.13% SEK 9.7m
Kristina Ekblad	Chief Financial Officer	4.2yrs	データなし	データなし
Lars Ångman	Investment Manager	2.5yrs	データなし	0.034% SEK 2.5m

3.7yrs

平均在職期間

経験豊富な経営陣: MCAPの経営陣は経験豊富であると考えられます ( 3.6年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Karl Tobieson	Chairman	2.6yrs	SEK 425.00k	1.23% SEK 90.7m
Torgny Svensson	Member of Scientific Advisory Board	no data	データなし	データなし
Lena Söderström	Independent Director	2.2yrs	SEK 175.00k	データなし
Karl-Olov Fagerström	Member of Scientific Advisory Board	no data	データなし	データなし
Staffan Nilsson	Member of Scientific Advisory Board	no data	データなし	データなし
Gunnar Kratz	Member of Scientific Advisory Board	no data	データなし	データなし
Holland Cheng	Member of Scientific Advisory Board	no data	データなし	データなし
Otto Ankarcrona	Independent Director	1.5yrs	SEK 175.00k	データなし
David Jern	Independent Director	2.6yrs	SEK 175.00k	データなし
Malin Enarson	Independent Director	1.5yrs	SEK 175.00k	データなし
Anna Torner	Independent Director	2.2yrs	SEK 175.00k	データなし

2.2yrs

平均在職期間

53yo

平均年齢

経験豊富なボード: MCAPの取締役会は経験豊富ではない ( 2.1年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

MedCap マネジメント

マネジメント 基準チェック /34

主要情報

経営陣の近況

MedCap AB (publ), Annual General Meeting, May 06, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Recent updates

Now 21% undervalued

Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)

MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable

Now 21% undervalued

MedCap AB (publ) to Report Q1, 2025 Results on Apr 29, 2025

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

First quarter 2024 earnings released: EPS: kr3.78 (vs kr1.68 in 1Q 2023)

MedCap AB (publ), Annual General Meeting, May 06, 2024

MedCap AB (publ) to Report Fiscal Year 2024 Results on Jan 31, 2025

MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce

Full year 2023 earnings released: EPS: kr11.63 (vs kr7.94 in FY 2022)

Investor sentiment improves as stock rises 19%

Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?

MedCap AB (publ) to Report Q3, 2024 Results on Oct 25, 2024

Third quarter 2023 earnings released: EPS: kr2.59 (vs kr2.47 in 3Q 2022)

MedCap AB (publ) to Report First Half, 2024 Results on Jul 19, 2024

Second quarter 2023 earnings released: EPS: kr3.16 (vs kr1.42 in 2Q 2022)

MedCap AB (publ) (OM:MCAP) signed an agreement to acquire SurgiCube International B.V. for €8 million.

Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?

MedCap AB (publ) to Report Q1, 2024 Results on May 03, 2024

First quarter 2023 earnings released: EPS: kr1.68 (vs kr1.32 in 1Q 2022)

Full year 2022 earnings released: EPS: kr7.94 (vs kr6.52 in FY 2021)

These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: kr2.47 (vs kr1.73 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease

Now 21% undervalued

Now 21% undervalued

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

High number of new and inexperienced directors

MedCap AB (publ) to Report Q2, 2023 Results on Jul 28, 2023

MedCap AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

High number of new and inexperienced directors

MedCap AB (publ) to Report Q1, 2023 Results on May 03, 2023

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?

MedCap AB (publ) to Report Q4, 2022 Results on Feb 10, 2023

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly

Investor sentiment improved over the past week

Now 22% undervalued after recent price drop

High number of new directors

Chief Executive Officer recently bought kr348k worth of stock

Investment Manager recently bought kr828k worth of stock

Third quarter 2021 earnings released: EPS kr1.73 (vs kr0.89 in 3Q 2020)

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

Second quarter 2021 earnings released: EPS kr1.06 (vs kr1.33 in 2Q 2020)

Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Independent Chairman of the Board recently bought kr1.1m worth of stock

Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock

Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher

Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?

Revenue and earnings beat expectations

Full year 2020 earnings released: EPS kr4.36 (vs kr4.10 in FY 2019)

New 90-day low: kr193

MedCap (STO:MCAP) Could Easily Take On More Debt

Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?

An unknown buyer acquired 10.1% stake in MedCap AB (publ) (OM:MCAP) from Bure Equity AB (publ) (OM:BURE).

Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?

MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?

If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today

Market bids up stock over the past week

New 90-day high: kr233

Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?

Revenue and earnings miss expectations

Third quarter 2020 earnings released: EPS kr0.89

New 90-day high: kr227

New 90-day high - kr207

マネジメント基準チェック /34